Accrued Expenses

12 Months Ended

Dec. 31, 2020

Payables and Accruals [Abstract]

Accrued Expenses

Note 5. Accrued Expenses

The following is a summary of the Company’s accrued expenses:

	As of December 31,
	2020		2019
Clinical trial expenses	$	2,510,111	$	3,020,030
Other		128,197		137,356
Total	$	2,638,308	$	3,157,386